Market revenue in 2023 | USD 409.5 million |
Market revenue in 2030 | USD 262.3 million |
Growth rate | -6.2% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 85.52% in 2023. Horizon Databook has segmented the France real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
The primary factor expected to facilitate market growth is several research institutions engaged in developing PCR products. In April 2020, researchers developed a multiplex Droplet Digital PCR (ddPCR) to detect ESR1 mutation.
This product is based on a drop-off assay that detects E380Q, L536R, Y537C, Y537N, Y537S, and D538G gene mutations. Furthermore, in November 2019, the International Society for Human and Animal Mycology developed a real-time qPCR for diagnosing Pneumocystis Pneumonia (PCP) under the Fungal PCR Initiative.
Moreover, favorable reimbursement policies and product launches are anticipated to support market demand over the forecast period. For instance, in May 2020, THERADIAG announced the approval for AmpliCube Coronavirus SARS-Cov-2 by the National Reference Center of Paris (CNR).
Horizon Databook provides a detailed overview of country-level data and insights on the France real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into France real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account